Activating the immune system could treat obesity and diabetes

June 5, 2014, Cell Press

Obesity is a worldwide epidemic that is causing alarming rates of diabetes and cardiovascular disease, but currently there is a lack of effective drug treatments. Two unrelated studies published by Cell Press June 5th in the journal Cell reveal an important role for immune pathways in activating good types body fat, called brown and beige fat, which burn stored calories, reduce weight, and improve metabolic health. The findings could pave the way for much-needed treatments for obesity and related metabolic diseases.

"The idea that metabolic health can be improved by activation of in fat is pretty amazing," says senior study author Bruce Spiegelman of the Dana-Farber Cancer Institute and Harvard Medical School. "This research reveals an exciting new class of potential treatments that could one day be used for -related disorders."

Human infants have large amounts of heat-generating brown fat to protect them from extreme cold, and scientists recently discovered that adult humans retain small amounts of brown fat consisting mainly of a subtype known as beige fat. Cold exposure or exercise can activate brown or beige fat, which burn stored calories and protect mammals from hypothermia, obesity, and metabolic problems. Despite their therapeutic potential for treating these conditions, relatively little was known about the molecular pathways that trigger the formation of these good types of fat.

To address this question in the new study, Spiegelman and Rajesh Rao of the Dana-Farber Cancer Institute and Harvard Medical School focused on a recently identified protein called PGC-1alpha4, which promotes muscle growth in response to resistance exercise. They discovered that PGC-1alpha4 stimulates the secretion of a newly identified hormone called meteorin-like (Metrnl), which is released into the bloodstream and produced in muscle tissue after exercise and in after cold exposure in mice.

By converting energy-storing white fat to calorie-burning brown or beige fat, Metrnl increases energy expenditure and improves metabolic health in obese, diabetic mice. This hormone, which could potentially be suitable as a new therapy for obesity and diabetes, exerts these positive effects through activation of immune molecules called interleukin-4 and interleukin-13, as well as immune cells called macrophages located in fat tissue.

In another study published in the same issue, further light is shed on the question of immune responses and obesity by senior author Ajay Chawla of the University of California, San Francisco, who was motivated by his recent findings implicating the immune system in activating brown fat in response to cold environments. Chawla and his team have now revealed the circuit underlying beige fat activation in mice. They found that interleukin-4/13 signaling activated macrophages in white fat tissue, leading to the production of nervous system molecules required for converting white fat to beige fat. These findings reveal important new insights into how the immune system and nervous system work together to stimulate beige fat formation.

Moreover, the researchers found that mice with impaired signaling in this immune pathway produced less beige fat, showed lower energy expenditure, and were unable to maintain their body temperature in cold environments compared with normal mice. By contrast, treatment with interleukin-4 increased the formation of beige fat, reduced body weight, and improved metabolic health in obese mice.

"We were surprised by our observations that cold-induced recruitment of beige fat was almost entirely dependent on the . This goes against the established dogma because nutrient and energy metabolism has largely been thought to be under the control of the brain and endocrine system," Chawla says. "Having identified the cellular and molecular pathway that regulates the development of , it is now possible to target any of its components to stimulate caloric expenditure and treat obesity."

Explore further: Immune system molecules may promote weight loss, study finds

More information: Cell, Rao et al.: "Meteorin-like is a hormone that regulates immune-adipose interactions to increase beige fat thermogenesis." www.cell.com/cell/abstract/S0092-8674(14)00600-X

Cell, Qiu et al.: "Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat." www.cell.com/cell/abstract/S0092-8674(14)00601-1

Related Stories

Immune system molecules may promote weight loss, study finds

June 5, 2014
The calorie-burning triggered by cold temperatures can be achieved biochemically – without the chill – raising hopes for a weight-loss strategy focused on the immune system rather than the brain, according to a new study ...

Some fat cells can feel the cold

July 2, 2013
(Medical Xpress)—To survive in cold environments, mammals burn fat to produce heat. The breakdown of fat helps prevent obesity and related metabolic diseases, such as diabetes. Bruce Spiegelman and his colleagues at Harvard ...

'Beige' cells key to healthy fat

January 17, 2014
"Beige fat" cells found in healthy subcutaneous fat in mice play a critical role in protecting the body from the disease risks of obesity, report researchers at Dana-Farber Cancer Institute, who say their study findings may ...

Newly isolated 'beige fat' cells could help fight obesity

July 12, 2012
Scientists at Dana-Farber Cancer Institute have isolated a new type of energy-burning fat cell in adult humans which they say may have therapeutic potential for treating obesity.

Scientists find molecular link to obesity and insulin resistance in mice

September 27, 2012
Flipping a newly discovered molecular switch in white fat cells enabled mice to eat a high-calorie diet without becoming obese or developing the inflammation that causes insulin resistance, report scientists from Dana-Farber ...

Researchers create protein with potential for weight loss, diabetes treatment

May 2, 2014
(Medical Xpress)—It sounds like a magic bullet: Administer a protein, watch the subject lose weight. But that's exactly what University of Florida scientists found when they discovered a new way to deliver a protein that ...

Recommended for you

Genomics reveals key macrophages' involvement in systemic sclerosis

January 18, 2018
A new international study has made an important discovery about the key role of macrophages, a type of immune cell, in systemic sclerosis (SSc), a chronic autoimmune disease which currently has no cure.

First vaccine developed against grass pollen allergy

January 18, 2018
Around 400 million people worldwide suffer in some form or other from a grass pollen allergy (rhinitis), with the usual symptoms of runny nose, cough and severe breathing problems. In collaboration with the Viennese firm ...

Researchers discover key driver of atopic dermatitis

January 17, 2018
Severe eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition that is driven by an allergic reaction. In their latest study, researchers at La Jolla Institute reveal an important player that promotes ...

Who might benefit from immunotherapy? New study suggests possible marker

January 16, 2018
While immunotherapy has made a big impact on cancer treatment, the fact remains that only about a quarter of patients respond to these treatments.

Researchers identify new way to unmask melanoma cells to the immune system

January 16, 2018
system, which enables these deadly skin cancers to grow and spread.

How the immune system's key organ regenerates itself

January 15, 2018
With advances in cancer immunotherapy splashing across headlines, the immune system's powerful cancer assassins—T cells—have become dinner-table conversation. But hiding in plain sight behind that "T" is the organ from ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.